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Abstract: Reasons for the development of chronic tendon pathologies are still under debate and
more basic knowledge is needed about the different diseases. The aim of the present study was
therefore to characterize different acute and chronic Achilles tendon disorders. Achilles tendon
samples from patients with chronic tendinopathy (n = 7), chronic ruptures (n = 6), acute ruptures
(n = 13), and intact tendons (n = 4) were analyzed. The histological score investigating pathological
changes was significantly increased in tendinopathy and chronic ruptures compared to acute ruptures.
Inflammatory infiltration was detected by immunohistochemistry in all tendon pathology groups,
but was significantly lower in tendinopathy compared to chronic ruptures. Quantitative real-time
PCR (qRT-PCR) analysis revealed significantly altered expression of genes related to collagens and
matrix modeling/remodeling (matrix metalloproteinases, tissue inhibitors of metalloproteinases) in
tendinopathy and chronic ruptures compared to intact tendons and/or acute ruptures. In all three
tendon pathology groups markers of inflammation (interleukin (IL) 1β, tumor necrosis factor α, IL6,
IL10, IL33, soluble ST2, transforming growth factor β1, cyclooxygenase 2), inflammatory cells (cluster of
differentaition (CD) 3, CD68, CD80, CD206), fat metabolism (fatty acid binding protein 4, peroxisome
proliferator-activated receptor γ, CCAAT/enhancer-binding protein α, adiponectin), and innervation (protein
gene product 9.5, growth associated protein 43, macrophage migration inhibitory factor) were detectable,
but only in acute ruptures significantly regulated compared to intact tendons. The study gives an
insight into structural and molecular changes of pathological processes in tendons and might be used
to identify targets for future therapy of tendon pathologies.
Keywords: chronic tendon pathologies; acute rupture; human; tendon structure; matrix;
modeling/remodeling; inflammation; fat; innervation
1. Introduction
Achilles tendon pathologies can either be due to an acute injury, mostly occurring in relation
to sports, or have a chronic background and are called tendinopathies. Achilles tendinopathy is
one of the most frequent tendon pathologies caused by overuse or overload stresses, which lead to
repetitive micro-traumata [1]. It is characterized by swelling, pain and reduced function [2] and was
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supposed to represent a failed healing response of the tendon [3]. Characteristics of tendinopathic
tendons are excessive proliferation of tenocytes and changes in tenocyte morphology, disruption
of collagen fibers, increase in non-collagenous matrix such as glycosaminoglycans (GAG) and fat
tissue as well as neovascularization [4–9]. Furthermore, it was reported that alterations in the
expression of matrix metalloproteinases (MMPs) and their natural antagonists, the tissue inhibitors of
metalloproteinases (TIMPs), which regulate the modeling and remodeling in the tendons, are linked to
tendinopathy [10–13]. The presence of immune cells and inflammatory processes in tendinopathy is
still under debate [14–17]. Several studies using classical histological evaluations negate the presence
of immune cells in chronic tendinopathy [2,9,18]. On the other hand, more recent studies found
inflammatory infiltration of B cells, T cells, macrophages, mast cells and/or natural killer cells [19–24].
Furthermore, it was hypothesized that inflammation is only relevant in the initiation of tendinopathy
rather than the progression of the disease process [25]. It was shown that chronic painful tendons are
associated with an increase in neuromediators like the neurotransmitter glutamate and glutamineric
receptors, substance P and protein gene product 9.5 (PGP9.5) [26–29], as well as an increase in
inflammatory markers such as cluster of differentiation (CD)206 and CD45 [27]. Additionally, it was
shown that the pro-inflammatory cytokines cyclooxygenase-2 (COX2) and interleukin-6 (IL6) were
upregulated in painful versus asymptomatic Achilles tendons [30].
Taken together it seems obvious that tendinopathy is a multifactorial process and more
basic knowledge is still needed to better understand the development and progression of the
disease. Therefore, the present approach aimed to characterize different tendon pathologies, such as
tendinopathy and chronic Achilles tendon ruptures compared to acute ruptures and intact tendons
regarding molecular and histological alterations in matrix production, modeling and remodeling,
adipogenic differentiation, as well as inflammation and innervation.
2. Results
2.1. Histological Analysis
The intact cadaveric tendons showed compact collagen fiber bundles with long flat tenocytes
(Figure 1) and were all scored with zero points. The tendinopathy and chronic rupture groups showed
a significantly increased histological score compared to the acute ruptured tendons (Figure 2A).
Looking in detail, the tendon architecture was fully disturbed in all acute ruptured tendons,
which was significantly higher scored compared to the tendinopathic tendons (Figures 1 and 2B).
The amount of aligned collagen did not significantly change between the groups (Figure 2C). In the
tendinopathy and chronic ruptures, a high GAG content was detected (Figure 1). The difference was
significant in the tendinopathy group compared to the acute ruptures (Figure 2D). Fat infiltration
was seen in four tendinopathy tendons and in two chronic ruptures and was significantly higher
in the tendinopathic tendons compared to the acute ruptures, where no fat tissue was visible
(Figures 1 and 2E). The tendinopathy and chronic ruptures were histologically characterized by
a tightly packed structure with significantly higher vascularity and hypercellularity. In acute
ruptured tendons, vessel formation was low and mostly concentrated at the tendon edges, whereas
in intact tendons vessels were only present between the collagen fiber bundles (Figures 1 and 2F,G).
A significantly lower amount of inflammatory cells (CD45+) was found in the tendinopathy group
compared to the chronic ruptures. High amounts of inflammatory cells were also found in acute
ruptured tendons (Figure 2H). The CD45+ cells were primarily identified as monocytes/macrophages
(CD68+) (Figure 3).
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Figure 1. Exemplary histologies of intact tendons, tendinopathic tendons, chronic ruptures and acute 
ruptures using Movat Pentachrome (MP) staining (tendon architecture, glycosaminoglycan (GAG) 
and fat tissue (lipid vacuoles)), α smooth muscle actin (αSMA) staining (vascularity) and Hematoxylin 
Eosin (HE) staining (cellularity). F: fat tissue, V: vessels, C: cell clusters. The Movat Pentachrome 
staining used stains collagen in yellow to brown, mature collagen in red [31], GAG ground substance 
in turquois, cell nuclei in blue to black and cytoplasm stains reddish. 
 
Figure 1. Exemplary histologies of intact tendons, tendinopathic tendons, chronic ruptures and acute
ruptures using Movat Pentachrome (MP) staining (tendon architecture, glycosaminoglycan (GAG) and
fat tissue (lipid vacuoles)), α smooth muscle actin (αSMA) staining (vascularity) and Hematoxylin
Eosin (HE) staining (cellularity). F: fat tissue, V: vessels, C: cell clusters. The Movat Pentachrome
staining used stains collagen in yellow to brown, mature collagen in red [31], GAG ground substance
in turquois, cell nuclei in blue to black and cytoplasm stains reddish.
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Figure 2. Evaluation of histological score: (A) Total histological score reaching 18 points as maximum, 
which would indicate a highly degenerated tendon. (B) Tendon architecture as indicator for the 
disturbance of the tendon structure (0–3 points). (C) Amount of aligned collagen quantified using 
ImageJ (0–100%). (D) GAG content (0–3 points, MP staining). (E) Fat tissue quantified using ImageJ 
(0–100%, MP staining). (F) Cellularity (0–3 points, HE staining). (G) Vascularity (0–3 points, αSMA 
staining). (H) Inflammatory cells (not included in histological score, CD45 staining). Data are given 
as individual dot plots with median and interquartile range. 
 
Figure 3. Exemplary images of inflammatory cell infiltration visualized by immunohistological CD45 
(leucocytes) and CD68 (monocytes/macrophages) staining in tendinopathic tendons, chronic ruptures 
and acute ruptures. 
  
Figure 2. Evaluation of histological score: (A) Total histological score reaching 18 points as maximum,
which would indicate a highly degenerated tendon. (B) Tendon architecture as indicator for the
disturbance of the tendon structure (0–3 points). (C) Amount of aligned collagen quantified using
ImageJ (0–100%). (D) GAG content (0–3 points, MP staining). (E) Fat tissue quantified using ImageJ
(0–100%, MP staining). (F) Cellularity (0–3 points, HE staining). (G) Vascularity (0–3 points, αSMA
staining). (H) Inflammatory cells (not included in histological score, CD45 staining). Data are given as
individual dot plots with median and interquartile range.
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Figure 3. Exemplary images of inflammatory cell infiltration visualized by immunohistological CD45
(leucocytes) and CD68 (monocytes/macrophages) staining in tendinopathic tendons, chronic ruptures
and acute ruptures.
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2.2. Gene Expression
Using quantitative real-time PCR (qRT-PCR), the collagens Col1A1, Col3A1 and Col5A2 were found
to be significantly upregulated in the tendinopathies and chronic ruptures compared to the intact
control and the acute ruptured tendons (Figure 4A–C). The Col1A1/Col3A1 ratio was not regulated.
When looking at matrix degrading enzymes, the gene expression of the collagenase MMP1
was significantly elevated in the acute ruptured tendons compared to all other groups, whereas
the expression of the collagenase MMP13 was significantly increased in the tendinopathy group
compared to the intact samples (Figure 4D,H). The gelatinase MMP2 was significantly upregulated
in the tendinopathy and chronic rupture group compared to the intact and acute ruptured tendons
(Figure 4E), but MMP9 was not affected. The expression of the stromelysines MMP3 and MMP10
was significantly decreased in the tendinopathy and chronic rupture groups compared to the acute
ruptured tendons (Figure 4F,G).
The expression of the MMP inhibitors was differentially regulated. TIMP1 expression was
significantly higher and TIMP3 and TIMP4 expression significantly lower in the acute ruptured tendons
compared to the other groups. TIMP2 expression was significantly elevated in the tendinopathy group
compared to the intact tendons and acute ruptures (Figure 4I–L).
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Figure 4. Relative gene expression of collagens (A–C), MMPs (D–H) and TIMPs (I–L) in tendinopathic 
tendons, chronic ruptures and acute ruptures given as fold to intact tendon tissue (horizontal line, 
mean value = 1). qRT-PCR data were normalized to the expression of the house keeping gene 18S 
rRNA with efficiency correction and presented as fold change to the mean of the intact tendons. 
Results are shown as individual dot plots with median and interquartile range. Significant differences 
between the intact tendons and the three tendon pathology groups are marked with a star (*) above 
the intact tendon and the respective significant group (T: tendinopathy, C: chronic ruptures, A: acute 
ruptures) and the p-value. The vertical dashed line separates the intact group from the tendon 
pathology groups. Significant differences between the three tendon pathology groups are marked 
with a spanning line above the groups and the individual p-values. p ≤ 0.05 was considered as 
statistically significant. 
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Figure 4. Relative gene expression of collagens (A–C), MMPs (D–H) and TIMPs (I–L) in tendinopathic
tendons, chronic ruptures and acute ruptures given as fold to intact tendon tissue (horizontal line,
mean value = 1). qRT-PCR data were normalized to the expression of the house keeping gene 18S rRNA
with efficiency correction and presented as fold change to the mean of the intact tendons. Results are
shown as individual dot plots with median and interquartile range. Significant differences between
the intact tendons and the three tendon pathology groups are marked with a star (*) above the intact
tendon and the respective significant group (T: tendinopathy, C: chronic ruptures, A: acute ruptures)
and the p-value. The vertical dashed line separates the intact group from the tendon pathology groups.
Significant differences between the three tendon pathology groups are marked with a spanning line
above the groups and the individual p-values. p ≤ 0.05 was considered as statistically significant.
The tendon related transcription factor scleraxis (SCX) was not significantly altered between the
four groups. The tendon related proteoglycan tenomodulin (TNMD) was significantly upregulated in
chronic versus acute ruptured tendons (Figure 5A).
When looking at inflammatory markers, the IL33 expression was significantly decreased in the
acute ruptures compared to the intact tendons and chronic ruptures (Figure 5B). The IL33 receptor
soluble ST2 (sST2) was not regulated between the groups . In the group of pro- and anti-inflammatory
cytokines only IL6 and IL10 showed significant upregulation in the acute ruptures compared to the
intact and/or tendinopathic tendons (Figure 5C,D), whereas the expression of IL1β, tumor necrosis
factor α (TNFα) and transforming growth factor β1 (TGFβ1) did not change between the groups.
The expression of the T-cell marker CD3 was not regulated, but the expression of the
onocyte/macrophage marker CD68 was significantly upregulated in the acute ruptures compared
to the intact tendons (Figure 5E). The acrophage polarization markers CD80 and CD206 did not
significantly change.
The expression of acrophage igration inhibitory factor (MIF), a nerve regeneration marker,
and P P9.5, a general nerve arker, as significantly increased in acute ruptures compared to the
i tact a c ro ic r t res or te inopathy group, respectively (Figure 5F,G). The expression of the
er e r t ar er r t ass ciate r tei 43 ( P43) as not regulated. The expression of the
i - ss ci te factor COX2 was significantly increased in the acute r ptures compared to the chronic
ruptures (Figure 5H).
l i t t f t etabolis , significantly lower expre sion of fatty acid binding protein
, i li i t t r , enhancer-binding
t r s c pared to the intact tendons. On the other hand,
and P ARγ expression was significantly higher in chronic uptures and tendinopathic tendons
when compared to acute rupt r s (Figure 5H,I). The expression of adiponectin (ADIPOQ) was not
significantly affected.
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the immune cell marker CD68 (E), the nerve markers MIF and PGP9.5 (F–G), the pain marker COX2 (H),
and the fat markers FABP4, PPARγ and CEBPα (I–K) in tendinopathic tendons, chronic ruptures and
acute ruptures given as fold to intact tendon tissue (horizontal line, mean value = 1). qRT-PCR data
were normalized to the expression of the house keeping gene 18S rRNA with efficiency correction
and presented as fold change to the mean of the intact tendons. Results are shown as individual dot
plots with median and interquartile range. Significant differences between the intact tendons and the
three tendon pathology groups are marked with a star (*) above the intact tendon and the respective
significant group (T: tendinopathy, C: chronic ruptures, A: acute ruptures) and the p-value. The vertical
dashed line separates the intact group from the tendon pathology groups. Significant differences
between the three tendon pathology groups are marked with a spanning line above the groups and the
individual p-values. p ≤ 0.05 was considered as statistically significant.
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3. Discussion
The present study aimed at investigating the structural, cellular, as well as molecular
characteristics of different tendon pathologies. As tendinopathy seems to be a multifactorial process,
a variety of factors and processes related to tendon matrix, modeling and remodeling, inflammation,
fatty infiltration and innervation were analyzed to better understand possible reasons for the
development and progression of degenerative Achilles tendon pathologies.
The tendinopathy and chronic rupture groups showed a disturbed tendon structure and
were histologically characterized by a tightly packed extracellular matrix (ECM) with loss of
the hierarchical structure, high amounts of non-collagenous matrix such as GAG and fat, high
vascularity and hypercellularity, as it was reported previously [4–9]. Interestingly, despite the different
pathomechanisms of the two degenerative tendon pathologies, which is on the one hand the overused
tendon with repetitive micro-traumata (tendinopathy) and on the other hand the tendons with overseen
or old macro-trauma (chronic ruptures), both groups showed similar characteristics. Only the lower
amount of inflammatory cell infiltration (CD45+) in the tendinopathy group was significantly different
compared to the chronic ruptures. Additionally, the tendinopathy group showed more distinct
differences than the chronic ruptures compared to the intact and acute ruptured tendons. Overall,
the acute ruptured tendons showed the strongest alterations compared to the intact tendons for
nearly all analyzed processes (modeling/remodeling, inflammation, immune cells, fatty infiltration
and innervation), whereas the tendinopathy and chronic ruptured tendons only showed significant
differences to the intact controls related to collagen and matrix modeling/remodeling.
The disturbed matrix metabolism as seen in the histology in the tendinopathy and chronic
ruptured tendons was displayed in the altered gene expression of the collagens as well as MMPs
and TIMPs. The expression of COL1A1, COL3A1 and COL5A2 was significantly elevated compared
to intact and acute ruptured tendons. Accordingly, this increase in collagen expression was also
reported by other authors [12,30,32]. An increase in type III and V collagen expression was often
reported to result in inferior biomechanical properties [33,34]. Furthermore, type V collagen variants
were associated with chronic Achilles tendinopathy [35,36]. The loss of ability to form a hierarchical
tendon structure seems to be a further important characteristic in tendinopathy. TNMD—a tendon
proteoglycan responsible for collagen fiber maturation [37,38]—was significantly upregulated in the
chronic rupture group compared to acute ruptures and not regulated in the tendinopathy group.
Non-regulation of factors regulating fibrillogenesis were also reported previously for tendinopathy
versus healthy tendons [32], which partly fits with the present findings. IL33—a cytokine having
a pivotal role in innate and acquired immune responses—was described to be important in early
tendinopathy. Here it regulates the transition of collagen type I to type III synthesis through its cognate
receptor ST2, which exists in a membrane-bound as well as soluble cognate form (sST2) [39]. Presently,
IL33 expression was significantly decreased in acute ruptured versus intact tendons but significantly
increased in chronic ruptures compared to acute ruptures. This is supporting the previous hypothesis
that recurrent micro-traumata lead to an increase in IL33 expression and thus matrix degradation and
inflammation, which might lead to an impaired healing response [39] and possibly to a lower tendon
strain and a higher susceptibility for Achilles tendon rupture.
Next to the collagens, matrix degrading enzymes were also regulated in the tendinopathy and
chronic ruptured tendons. The expression of the gelatinase MMP2 was significantly increased in
both groups, which is in accordance to previous findings [32]. Additionally, the collagenase MMP13
expression was significantly upregulated in the tendinopathy group compared to the intact tendons.
The upregulation of the MMPs together with the mostly non-regulation of the TIMPs compared
to the intact tendons might lead to a possible MMP/TIMPs imbalance in the tendinopathy and
chronic rupture groups. Such an imbalance was hypothesized to lead to a failed tendon remodeling
process [40–42]. Additionally, the expression of MMP3 and MMP10, the stromelysines, which have an
important regulatory function on other MMPs [42], was significantly decreased in the tendinopathy
and chronic rupture groups compared to the acute ruptured tendons. A decrease of MMP-3 expression
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was also reported by others and was hypothesized to lead to an incorrect remodeling process [12,42].
Present regulations regarding MMPs and TIMPs were previously also shown for tenocytes from aged
donors and with higher degenerative status of supraspinatus tendons [43]. Additionally, comparable
regulations were found in acute ruptured tendons, which were surgically treated at a later time-point
(7–10 days) post rupture compared to tendons, were the surgery was performed at an earlier time-point
(2–4 and 5–6 days) after Achilles tendon rupture [44]. As hypothesized previously, at a later time point
the tendons seem to turn into a degenerative direction, which can now be confirmed when comparing
it to the present tendinopathy and chronic rupture groups.
Interestingly, no significant changes for the tendinopathy and chronic rupture group compared to
intact tendons could be observed for the other processes such as inflammation, fatty infiltration and
innervation. An excessive inflammatory reaction was not present in the tendinopathy group and was
even reduced, as seen by a lower amount of inflammatory cells in the tendinopathy group compared
to the chronic ruptures in the histology. Inflammation is present in tendinopathy and chronic ruptured
tendons but seems to be less pronounced compared to the acute ruptured tendons, as the expression of
pro-and anti-inflammatory cytokines as well as inflammatory cell markers for T-cells and macrophages
was not distinctly different compared to the expression in intact tendons. The presence of inflammatory
cell infiltration in tendinopathy and chronic ruptures confirms several previous studies [19–24], but the
role of inflammation in the disease is still unclear but might only be important in the initiation
of tendinopathies [25]. However, inflammation seems to be more important in acute ruptures,
as indicated by the increased expression of the cytokines IL6 and IL10 and the macrophage marker
CD68. The increased expression of IL6 and CD68 might be linked to each other, as IL6 was reported
to promote the differentiation of monocytes into macrophages [45]. An increased IL6 expression
was also found by others in painful and ruptured versus asymptomatic tendons [30]. Interestingly,
IL6−/− mice showed inferior mechanical properties [46]. During acute tendon healing, the typical
processes such as inflammation (pro- and anti-inflammatory phase), proliferation, remodeling and
maturation proceed [47]. The present data suggest that in the acute ruptured tendons, which were
taken four to six days after rupture, the healing process is in the anti-inflammatory phase, as both
IL6 and IL10 have anti-inflammatory properties [48] and the pro-inflammatory cytokines IL1β and
TNFα were not regulated. This is furthermore underlined by unregulated macrophage polarization
(unchanged CD80, CD206 expression), as M1 macrophages have pro- and M2 macrophages have
anti-inflammatory properties [49]. However, macrophage polarization was previously described to
be involved in tendinopathy, with M2 macrophages or CD206 expression is dominating in chronic
tendon pathologies [24,50]. Additionally, we could show previously that tenocytes respond to an
inflammatory environment and influence macrophage polarization [51]. Presently, no regulation in
the expression of macrophage polarization markers could be observed, either in acute ruptures nor in
tendinopathy or chronic ruptured tendons, which might be caused by limitations in the used methods.
A clear fatty infiltration was detected in the histological sections for tendinopathy and partly
chronic tendon ruptures. However, no significant differences between gene expression levels of the
adipogenic factors FABP4, PPARγ and ADIPOQ were detected between tendinopathy and chronic
ruptures with intact tendons. The presence of adipogenic factors in intact tendons is not unusual,
as isolated tenocytes of supraspinatus tendons also expressed adipogenic factors without adipogenic
stimulation [52–54]. Additionally, others found a reduced expression of markers for lipolysis and
ADIPOQ and an increase in markers for fatty acid β-oxidation in Kargers fat pad in patients with
Achilles tendinopathy, which was discussed as being a paradox but might be caused by different
regulation of mRNA expression and actual enzyme activity [55]. However, presently the increase in
fat tissue in the tendinopathy and chronic ruptured tendons compared to the acute ruptured tendons
was confirmed by the gene expression data, with an increased FABP4 and PPARγ expression in
tendinopathy and chronic ruptured tendons. It was previously shown that adipose tissue plays an
important role in inflammation [55,56] and that ADIPOQ might have pro-inflammatory properties
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in joint diseases [57]. However, the present results were not able to confirm a relationship between
adipose tissue and inflammation in tendinopathy and chronic ruptures.
Innervation could be demonstrated in the present study, with expression of the general nerve
marker PGP9.5, the nerve growth marker GAP43 and the nerve regeneration marker MIF [58]. PGP9.5
was previously found in the plantaris tendon and peritendinous tissue of patients with Achilles
tendinopathy, indicating strong innervation [28] and was additionally associated with pain [27]. MIF
expression was not described in tendons before and no significant differences in expression were
observed between tendinopathy/chronic ruptures and intact tendons. However, innervation seems to
play a more important role in the acute situation, as acute ruptured tendons expressed higher amounts
of PGP9.5 and MIF compared to tendinopathy, and chronic/intact tendons, respectively. The further
pain-associated factor COX2 was upregulated in acute ruptured tendons compared to chronic ruptured
tendons. An increased COX2 expression was previously found in painful Achilles tendons but even
more in acute ruptured Achilles tendons [30], which underlines the present findings.
Limitations
Most regulations were observed for the acute ruptured tendons, which might be caused by the
higher sample number in the group. The sample number is relatively low for the intact, tendinopathy
and chronic rupture group, which might account for the less distinct regulations. To increase the
sample number for intact tendons another tendon location could have been used, as performed in
other studies [24,59]. However, we decided to use the same tendon as control to avoid regulations
due to a different biomechanical stimulation of the tendons and surrounding tissues. The intact
Achilles tendons derived from patients with indications for foot surgery not related to primary Achilles
tendon pathology. Samples were taken during Achilles tendon lengthening with tendon transfer for
peroneal paresis and implantation of total ankle arthroplasty. These indications might harm the normal
movement of the foot and therefore also Achilles tendon, which could have affected the present results
of the intact group.
Several analyzed factors and mechanisms are linked to each other, such as MMPs and cytokines,
as MMPs also have non-ECM substrates such as IL1β and TNFα [60]. The present study is limited to
a descriptive histological and molecular biological level as special mechanisms and interplays cannot
be clarified. The available tendon material was limited and we decided to use a descriptive (histology)
and quantitative (qRT-PCR) method to analyze the tendon samples in the most comprehensive
way. A quantitative protein analysis to validate the expression data was not possible with the
limited material.
Regarding the donor demographics, the age of the groups varied and donors with chronic ruptures
were significantly older compared to donors with acute ruptures. As we showed previously that the
age of donors can affect the biological characteristics of tenocytes of the rotator cuff [43,54], we are
not able to fully exclude that changes between the two groups are partially affected by the varying
donor age. However, for the acute rupture group we deliberately choose a cohort of young recreational
sportsmen to avoid analyzing tendons with degenerative preconditions to better border them from the
two chronic tendon pathology groups.
4. Materials and Methods
4.1. Tendon Sampling
Achilles tendon biopsies from patients suffering from insertional Achilles tendinopathy (n = 7) or
chronic delayed diagnosed ruptures (n = 6; with a trauma to surgery duration of ≥3 weeks) were taken
at surgery. Additionally, acute ruptured Achilles tendons from recreational sportsmen, which were
taken during minimal invasive Achilles tendon reconstruction 4 to 6 days (mean 4.9 ± 0.9 days) after
rupture (n = 13) were used for comparison. Patients who received oral medication or local injections,
which might influence tendon structure (systemic cortisone, antibiotics and anabolic steroids) were
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excluded. Intact tendons from patients undergoing surgery not related to primary tendon pathology
served as control for RNA analysis (n = 4) and from cadavers for histological evaluations (n = 5).
The donor demographics are summarized in Table 1. The samples of the intact human Achilles tendons
as well as the acute ruptured tendons were partly used in a previous study [44]. The study was
approved by the local institutional review board (EA2/074/14, 02 July 2014) and all patients gave their
written informed consent prior to surgery. The tendon samples were divided into two equal parts and
analyzed histologically and by qRT-PCR.
Table 1. Donor demographics.
Group n-Value Age (Mean± SD) BMI (Mean± SD) Sex (Female/Male)
Tendinopathy 7 45.3 ± 7.9 years 26.8 ± 5.2 3/4
Chronic Rupture 6 52.2 ± 12.6 years * 28.6 ± 5.2 1/5
Acute Rupture 13 32.0 ± 3.1 years * 23.5 ± 1.9 2/11
Intact (patient) 4 37.8 ± 12.8 years 30.5 ± 3.5 2/2
Intact (cadaver) 5 83.4 ± 2.9 years - 3/2
* Significantly different (p = 0.005).
4.2. Histological Evaluation
Tendon samples were processed as published previously for histological evaluation [44]. They were
fixed in 4% paraformaldehyde solution for 24 h until rinsing, automatic dehydration and paraffin
embedding. Slices 4 µm thick were cut and stained with Hematoxylin Eosin (HE), Movat Pentachrome
(MP) and the antibody against α-smooth muscle actin (αSMA). A modified Movin score [9] was used to
evaluate pathologic changes in tendon structure as described previously [44]. The following parameters
were evaluated: tendon architecture, amount of aligned collagen, GAG content, fat content, cellularity
and vascularity. A total of 18 points could be reached with each parameter being scored between 0 and 3
(0 = normal, 1 = slightly abnormal, 2 = abnormal and 3 = markedly abnormal) (for classification, see [44]).
The parameters were quantified visually by three blinded independent observers, whereas 2 observers
independently scored the samples and one decided in case of discrepancy. Using ImageJ (ImageJ 1.44i,
Wayne Rasband, National Institute of Health, Bethesda, MD, USA) the amount of fat tissue and aligned
collagen was quantified. CD45 and CD68 immunohistochemical stainings were performed to detect
inflammatory cell infiltration.
4.3. Immunohistochemistry
Immunohistochemical stainings were performed to analyze vessel formation (αSMA, monoclonal
mouse anti-human smooth muscle actin, 1:200, Dako, Jena, Germany, M0851), as well as inflammatory
cell infiltration (CD45, monoclonal mouse Anti-Human CD45, 1:100, Dako, M0701, and CD68,
monoclonal mouse anti-human CD68, 1:40, Acris Antibodies GmbH, Herford, Germany). Primary
antibodies were incubated for 1 h and stainings afterwards processed with the ZytoChem-Plus AP Kit
(Broad Spectrum, AP060, Zytomed, Berlin, Germany) and the Alkaline Phosphatase Substrate Kit I
(Sk-5100, Vector, Peterborough, UK). Mayer’s Hematoxylin (Sigma-Aldrich, Taufkirchen, Germany)
was used for counterstaining. Isotype control and antibody only staining served as negative controls.
4.4. qRT-PCR
qRT-PCR was performed as described previously [44]. Tendon samples were incubated in
RNAlater (Qiagen, Hilden, Germany) for transport and stored at −80 ◦C until used for RNA isolation.
A liquid nitrogen cooled steel mortar system and Trifast peqGOLD (Peqlab, Erlangen, Germany)
were used for tissue homogenization. Phase separation was performed using chloroform. RNA
was purified with the NucleoSpin RNA Kit (Macherey-Nagel, Düren, Germany) according to the
manufacturer and afterwards quantified with the Nanodrop ND1000 system (Peqlab, Erlangen,
Germany). Exemplary analysis of RNA integrity was performed with the 2100 Bioanalyzer and
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the Agilent 6000 Pico Kit (Agilent, Santa Clara, CA, USA) and revealed good RNA quality with only
slight RNA degradation (values between 6.7 and 6.9). cDNA synthesis of 100 ng RNA template was
performed with the qScript cDNA Supermix (Quanta Biosciences, Gaithersburg, MD, USA). Expression
levels of collagens (Col1A1, Col3A1, Col5A2), tendon markers (SCX, TNMD), matrix degrading enzymes
(MMP1, MMP2, MMP3, MMP9, MMP10, MMP13) and its inhibitors (TIMP1, TIMP2, TIMP3, TIMP4),
pro- and anti-inflammatory cytokines (IL1β, TNFα, IL6, IL10, TGFβ1, COX2, IL33, sST2), immune
cell markers (CD3 (T-cells) and CD68 (monocytes/magrophages)), macrophage polarization markers
(CD80 (M1), CD206 (M2)), markers for adipogenic differentiation (FABP4, PPARγ, ADIPOQ, CEBPα)
as well as markers for innervation (PGP9.5, GAP43, MIF) were evaluated. The 18S rRNA was chosen
as housekeeping gene because it was most constant compared to hypoxanthine phosphoribosyl
transferase (HPRT) and 60S ribosomal protein L13 (RPL13). The SYBR Green Mastermix (Quanta
Biosciences) and the LightCycler 480 System (Roche, Mannheim, Germany) were utilized to perform
qRT-PCR. Primer 3 software was used to design all primer sequences (Freeware; Available online:
http://frodo.wi.mit.edu/primer3) except for TNMD [61] and IL1β [62]. Primer sequences were
produced by Tib Molbiol, Berlin, Germany (Table 2) and primer efficiencies were tested. The normalized
expression was calculated using the following efficiency corrected equation according to Simon [63]:
1) Normalized expression (NE) =
(Efficiency 18S) CT 18S
(Efficiency target) CT target
The normalized gene expression is given as fold gene expression to the intact tendons as
calculated below:
2) Fold gene expression =
NE pathologic tendons
Mean NE intact tendons
Table 2. qRT-PCR Primer.
Gene Accession No. Primer Sequence
18S rRNA NM_022551
Forward: 5′ CGGAAAATAGCCTTTGCCATC 3′
Reverse: 5′ AGTTCTCCCGCCCTCTTGGT 3′
COL1A1 NM_000088.3
Forward: 5′ TGACCTCAAGATGTGCCACT 3′
Reverse: 5′ ACCAGACATGCCTCTTGTCC 3′
COL3A1 NM_000090.3
Forward: 5′ GCTGGCATCAAAGGACATCG 3′
Reverse: 5′ TGTTACCTCGAGGCCCTGGT 3′
COL5A2 NM_000393
Forward: 5′ AGAAGCCTCCCAGAACATCA 3′
Reverse: 5′ ACAGTCTTGCCCACATTTCC 3′
MMP1 NM_002421.3
Forward: 5′ CACGCCAGATTTGCCAAGAG 3′
Reverse: 5′ GTCCCGATGATCTCCCCTGA 3′
MMP2 NM_ 004530
Forward: 5′ TGGATGATGCCTTTGCTCGT 3′
Reverse: 5′ CCAGGAGTCCGTCCTTACCG 3′
MMP3 NM_002422.3
Forward: 5′ TGGGCCAGGGATTAATGGAG 3′
Reverse: 5′ GGCCAATTTCATGAGCAGCA 3′
MMP9 NM_004994.2
Forward: 5′ GGGACGCAGACATCGTCATC 3′
Reverse: 5′ GGGACCACAACTCGTCATCG 3′
MMP10 NM_ 002425
Forward: 5′ CCACCTGGACCTGGGCTTTA 3′
Reverse: 5′ GAACTGGGCGAGCTCTGTGA 3′
MMP13 NM_002427.3
Forward: 5′ CCTTCCCAGTGGTGGTGATG 3′
Reverse: 5′ CGGAGCCTCTCAGTCATGGA 3′
TIMP1 NM_003254.2
Forward: 5′ TTGGCTGTGAGGAATGCACA 3′
Reverse: 5′ AAGGTGACGGGACTGGAAGC 3′
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Table 2. Cont.
Gene Accession No. Primer Sequence
TIMP2 NM_003255.4
Forward: 5′ CCTGAGCACCACCCAGAAGA 3′
Reverse: 5′ TCCATCCAGAGGCACTCGTC 3′
TIMP3 NM_000362.4
Forward: 5′ CCGAGGCTTCACCAAGATGC 3′
Reverse: 5′ GCCATCATAGACGCGACCTG 3′
TIMP4 NM_003256.3
Forward: 5′ GAAGCCAACAGCCAGAAGCA 3′
Reverse: 5′ TTCCCTCTGCACCAAGGACA 3′
TNMD NM_022144.2
Forward: 5′ TTGAAGACCCACGAAGTAGA 3′
Reverse: 5′ ATGACATGGAGCACACTTTC 3′
IL33 NM_033439
Forward: 5′ CCAACAGAAGGCCAAAGAAG 3′
Reverse: 5′ AAGGCAAAGCACTCCACAGT 3′
sST2 NM_003856
Forward: 5′ CAACAAGAGGAAGGGCAAAA 3′
Reverse: 5′ CAAATTCAGGGCCAGACAGT 3′
IL1β NM_000576
Forward: 5′ TCCAGGAGAATGACCTGAGC 3′
Reverse: 5′ GTGATCGTACAGGTGCATCG 3′
TNFα NM_000594
Forward: 5′ AGCCCATGTTGTAGCAAACC 3′
Reverse: 5′ GAGGTACAGGCCCTCTGATG 3′
IL6 NM_000600
Forward: 5′ TGAGGAGACTTGCCTGGTGA 3′
Reverse: 5′ TTGGGTCAGGGGTGGTTATT 3′
IL10 NM_000572
Forward: 5′ TGAGAACAGCTGCACCCACT 3′
Reverse: 5′ GGCAACCCAGGTAACCCTTA 3′
TGFβ1 NM_000660.4
Forward: 5′ AAGGACCTCGGCTGGAAGTG 3′
Reverse: 5′ AGGGCCAGGACCTTGCTGTA 3′
CD3 NM_000073
Forward: 5′ CTGGGAAGTAATGCCAAGGA 3′
Reverse: 5′ CCAACAGCAAGGACGAAAAT 3′
CD68 NM_001040059
Forward: 5′ CCACCTGCTTCTCTCATTCC 3′
Reverse: 5′ ATTGTACTCCACCGCCATGT 3′
CD80 NM_005191
Forward: 5′ GCAGGGAACATCACCATCCA 3′
Reverse: 5′ CAGGACAGCGTTGCCACTTC 3′
CD206 NM_002438
Forward: 5′ ACTGGGGCCAAGCTTCTCTG 3′
Reverse: 5′ CACAGCCACGTCCCTTCAAC 3′
MIF NM_002415
Forward: 5′ GGTTCCTCTCCGAGCTCACC 3′
Reverse: 5′ TAGACCCTGTCCGGGCTGAT 3′
PGP9.5 NM_004181
Forward: 5′ CCATACAGGCAGCCCATGAT 3′
Reverse: 5′ AGACCTTGGCAGCGTCCTTC 3′
GAP43 NM_002045
Forward: 5′ CCGGCAAAGCAGGAGAAACT 3′
Reverse: 5′ TGGAGGACGGCGAGTTATCA 3′
COX2 NM_000963
Forward: 5′ TAGAGCCCTTCCTCCTGTGC 3′
Reverse: 5′ TGGGGATCAGGGATGAACTT 3′
FABP4 NM_001442
Forward: 5′ ACTGGGCCAGGAATTTGACG 3′
Reverse: 5′ ATGACGCATTCCACCACCAG 3′
PPARγ NM_015869
Forward: 5′ AAAGTCCTTCCCGCTGACCA 3′
Reverse: 5′ GGCCACCTCTTTGCTCTGCT 3′
ADIPOQ NM_004797
Forward: 5′ TGACCAGGAAACCACGACTCA 3′
Reverse: 5′ CCGATGTCTCCCTTAGGACCA 3′
CEBPα NM_004364
Forward: 5′ AAGGCCAAGAAGTCGGTGGA 3′
Reverse: 5′ GGCGGTCATTGTCACTGGTC 3′
SCX Commercial Quantitect primer Assay Hs_SCXB_2_SG
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4.5. Statistics
Statistical analysis was performed using GraphPad Prism Version 7.0 (GraphPad Software,
San Diego, CA, USA). For qRT-PCR analysis, 4 groups were compared (intact, tendinopathy, chronic
ruptures and acute ruptures) and for histological evaluation 3 groups were compared (tendinopathy,
chronic ruptures and acute ruptures). ANOVA using the Kruskal Wallis Test was performed to analyze
significant differences between all groups. Dunn’s Multiple Comparison test was used for individual
group comparison between either the intact group with the three tendon pathology groups or the three
tendon pathology groups with each other. A p ≤ 0.05 was considered as statistically significant.
5. Conclusions
To sum up the present findings, the disturbed matrix metabolism, which is seen histologically,
as well as by an imbalanced MMP/TIMP expression and highly increased collagen expression, seems to
be the most important characteristic in tendinopathy and chronic ruptured tendons. Other mechanisms
such as inflammation and innervation are indeed present in tendinopathy and chronic ruptured
tendons, as indicated by CD45 and CD68 positive cells in the histological sections and the expression
of inflammatory cytokines and nerve markers, but seem to play a more important role in the acute
rupture situation. Targeting the disturbed matrix metabolism in chronic tendon pathologies might be
a helpful tool for improved treatment strategies in the future.
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